(±)Cyclazocine blocks the dopamine response to nicotine

NeuroReport

Volumn 10, Issue 4, 1999, Pages 693-696

  Maisonneuve, I M ^a   Glick, S D ^a  

^a ALBANY MEDICAL COLLEGE   (United States)

Author keywords

(+)Cyclazocine; ( )Cyclazocine; ( )Cyclazocine; Dopamine; Microdialysis; Nicotine; Nucleus accumbens

Indexed keywords

CYCLAZOCINE; DOPAMINE; NICOTINE; 3,4 DIHYDROXYPHENYLACETIC ACID; HOMOVANILLIC ACID; NARCOTIC ANTAGONIST; NICOTINIC AGENT;

ANIMAL EXPERIMENT; ARTICLE; DOPAMINE BRAIN LEVEL; DOPAMINE RELEASE; DOPAMINERGIC ACTIVITY; DRUG EFFECT; NONHUMAN; NUCLEUS ACCUMBENS; PRIORITY JOURNAL; RAT; REWARD; SMOKING; SMOKING CESSATION; ANIMAL; DRUG ANTAGONISM; ELECTROCHEMISTRY; EXTRACELLULAR SPACE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; MALE; METABOLISM; MICRODIALYSIS; SPRAGUE DAWLEY RAT; STEREOISOMERISM;

3,4-DIHYDROXYPHENYLACETIC ACID; ANIMALS; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CYCLAZOCINE; DOPAMINE; ELECTROCHEMISTRY; EXTRACELLULAR SPACE; HOMOVANILLIC ACID; MALE; MICRODIALYSIS; NARCOTIC ANTAGONISTS; NICOTINE; NICOTINIC AGONISTS; RATS; RATS, SPRAGUE-DAWLEY; STEREOISOMERISM;

EID: 0033577060     PISSN: 09594965     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001756-199903170-00006     Document Type: Article

References (17)

1. 1. Grenhoff J, Aston-Jones G and Svenson TH. Acta Physiol Scand 128 351-358 (1986).
2. 2. Carr LA, Rowell PP and Pierce WM Jr Neurochem Res 14, 511-515 (1989).
3. 3. Imperato A, Mulas A and Di Chiara G. Eur J Pharmacol 132, 337-338 (1986).
4. 4. Corrigall WA, Franklin KB, Coen KM and Clarke PB. Psychopharmacology (Berl) 107, 285-289 (1992).
5. 5. Corrigall WA and Coen KM. Psychopharmacology 104, 171-176 (1991)
6. 6. Archer S, Glick SD and Bidlack JM. Neurochem Res 21, 1369-1373 (1996).
7. 7. Glick SD, Visker KE and Maisonneuve IM. Eur J Pharmacol 357, 9-14 (1998).
8. 8. Paxinos G and Watson C. Stereotaxic Atlas of the Rat Brain. Orlando, FL: Academic Press, 1986.
9. 9. Church J and Lodge D. J Pharmacol Exp Ther 26, 636-645 (1990).
10. 10. Beart PM, O'Shea RD and Manallack DT. J Neurochem 53, 779-88 (1989).
11. 11. Di Chiara G and Imperato A. J Pharmacol Exp Ther 244, 1067-1080 (1988).
12. 12. Spanagel R, Herz A and Shippenberg TS. Proc Natl Acad Sci USA 89, 2046-2050 (1992).
13. 13. Karreman M, Wasterink BH and Moghaddam B. J Neurochem 67, 601-607 (1996).
14. 14. Debonnel G and De Montigny C. Life Sci 58, 721-734 (1996).
15. 15. Balfour DJK, Birrell CE, Woran RJ and Benwell MEM. Eur J Pharmacol 316, 153-156 (1996).
16. 16. Paul IA, Basile AS, Rojas E et al. FASEB J 7, 1171-1178 (1993).
17. 17. Venihaki M, Gravants A and Margioris AN. Life Sci 58, 75-82 (1995).